In-Development:
EM150 / Oral – Gastroenterology – Combination drug product under development for treatment of stomach problems such as Irritable Bowel Syndrome (IBS) and Ulcers.
EM151 / Oral – Oncology – An alkylating drug product under development for treatment of brain tumors and Hodgkin’s lymphoma.